Abivax (ABVX) Intangibles (2021 - 2026)
Abivax's (ABVX) quarterly Intangibles came in at $7.7 million in Q1 2026, up 11.28% year-on-year from $6.9 million in Q1 2025, and up 0.58% quarter-over-quarter from $7.7 million in Q4 2025.
Abivax (ABVX) Intangibles (2021 - 2026) Analysis & Trends
Abivax's Intangibles history runs 6 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- On a quarterly basis, Intangibles rose 11.28% year-over-year to $7.7 million in Q1 2026; TTM through Mar 2026 was $7.7 million, a 11.28% increase from a year earlier, with the FY2025 full-year figure at $7.7 million, up 7.53% from the prior year.
- Intangibles climbed to $7.7 million in Q1 2026 per ABVX's latest filing, from $7.7 million in the prior quarter.
- Across five years, Intangibles topped out at $7.7 million in Q1 2026 and bottomed at -$3294.7 in Q3 2024.
- The 5-year median for Intangibles is $7.1 million (2023), against an average of $6.6 million.
- Across the five-year window, Intangibles decreased 0.65% in 2024 and jumped 234502.99% in 2025, its largest moves.
- Year by year, Intangibles stood at $6.7 million in 2022, then gained by 5.41% to $7.1 million in 2023, then dropped by 0.65% to $7.1 million in 2024, then climbed by 8.92% to $7.7 million in 2025, then rose by 0.58% to $7.7 million in 2026.
- Per Business Quant, the three latest ABVX Intangibles figures stand at $7.7 million (Q1 2026), $7.7 million (Q4 2025), and $7.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 55.80 Mn |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | 7.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.73 Mn |
| Dec 31, 2025 | 7.69 Mn |
| Sep 30, 2025 | 7.72 Mn |
| Jun 30, 2025 | 7.48 Mn |
| Mar 31, 2025 | 6.95 Mn |
| Dec 31, 2024 | 7.06 Mn |
| Sep 30, 2024 | -3,294.66 |
| Jun 30, 2024 | 7.11 Mn |
| Dec 31, 2023 | 7.11 Mn |
| Dec 31, 2022 | 6.74 Mn |
| Dec 31, 2021 | 106,389.30 |